NEW YORK, July 22, 2026 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that i

NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inves

Baader Bank Aktiengesellschaft acquired a new position in Astrazeneca Plc (NYSE: AZN) in the undefin

Andra AP fonden bought a new position in shares of Astrazeneca Plc (NYSE: AZN) during the undefined

Astrazeneca (AZN) closed the most recent trading day at $164.52, moving 2.59% from the previous trad

Boston Common Asset Management LLC trimmed its position in shares of Astrazeneca Plc (NYSE: AZN) by

DekaBank Deutsche Girozentrale boosted its holdings in Astrazeneca Plc (NYSE: AZN) by 4,529.1% in th

I identify dividend stocks and REITs that could protect investors from AI bubble risks, geopolitics,

The FDA's approval of Merck (NYSE:MRK | MRK Price Prediction) enlicitide decanoate, marketed as Lipf

AstraZeneca (AZN) shares fell roughly 8% as the market opened on July 9, 2026. Investors who held AZ

NEW YORK, July 16, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors

AstraZeneca is licensing Zegfrovy from Dizal in a deal worth up to $1.5B, expanding its lung cancer

On July 27, AstraZeneca PLC will report its results for the second quarter of 2026. As a reminder, i

Ionis and AstraZeneca's Phase 3 ATTR-CM trial misses its primary goal, analyst says the outcome

Ionis and AstraZeneca said Phase 3 eplontersen missed its primary ATTR-CM endpoint, while secondary

U.S. stock futures mixed, Dow down 0.1%. Levi Strauss shares down 6.1%, Noah Holdings down 14%, Ioni

Study missed primary endpoint of composite outcome of cardiovascular (CV) mortality and recurrent CV

Sino Biopharma expanded its GSK partnership in China and signed an AstraZeneca licensing deal worth

Helix, the leading enterprise genomics company, today announced a multi-year relationship with Astra

Elizabeth Warren warns Trump's law pushed children off Medicaid and CHIP in many states, while a

Abbisko and AstraZeneca will jointly develop a Phase 1/2 NSCLC therapy combining lumipodlin with Tag

AstraZeneca reported positive HPP trial data while Enhertu gained EU approval for HER2-positive soli

Recommendation based on TROPION-Breast02 phase 3 trial where Daiichi Sankyo and AstraZeneca’s Datrow

As millions take GLP-1 drugs, packaged food giants face declining volumes while protein brands and s

Supreme Court lets Medicare drug price negotiations continue, rejecting pharma industry challenges t

The US Supreme Court turned away appeals from six pharmaceutical companies seeking to topple the Med

Democrat Sen. Peter Welch backs Trump's MFN drug pricing plan as bipartisan pressure over prescr

Trump administration proposes new IVF benefits rule aimed at expanding employer fertility coverage a

Eli Lilly plans to invest $4.5 billion in Indiana, expanding its U.S. manufacturing footprint and su

White House estimates Trump's drug pricing agreements could save $529 billion in next decade, bu

Tempus AI (TEM) Q1 results: Revenue up 36.1% to $348.1M, beating estimates. TEM raises 2026 outlook

Sen. Warren challenges Trump's 600% TrumpRx drug price claim using a glass of water.

Trump, in January, said "inflation has been defeated." Wall Street is now bracing for a 0.9%

According to a Bloomberg report, Trump may impose 100% tariffs on drugmakers without pricing deals,

U: 18% | Unity Software shares are trading higher after the company issued preliminary Q1 2026 reven

Amgen Inc. (NASDAQ: AMGN) and GSK plc (NYSE: GSK) are reportedly set to announce their partnership w

Sentiment Change Creates Opportunity

The stock markets is in a lackluster session on Thursday, with traders eagerly awaiting more clues o

  Monday saw 825 companies set new 52-week lows.

Companies Reporting Before The Bell • Mastercard Inc. (NYSE:MA) is expected to report quarterly ear

Stocks That Hit 52-Week Lows On Monday